Yasuda Enterprise Development logo

Yasuda Enterprise Development

Asia, Tokyo, Japan, Tokyo

Description

Yasuda Enterprise Development, a venture capital firm, finances technology companies based in Japan, the United States, and other countries.

Investor Profile

Yasuda Enterprise Development has made 35 investments, with 0 in the past 12 months and 3% as lead.

Stage Focus

  • Series B (34%)
  • Series Unknown (26%)
  • Series C (20%)
  • Series D (11%)
  • Series A (3%)
  • Series E (3%)
  • Series F (3%)

Country Focus

  • United States (66%)
  • Japan (20%)
  • United Kingdom (9%)
  • Switzerland (3%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Biopharma
  • Information Technology
  • Electronics
  • Hardware
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yasuda Enterprise Development frequently co-invest with?

Japan Asia Investment
Asia, Tokyo, Japan, Tokyo
Co-Investments: 5
Mitsui Global Investment
North America, California, United States, Menlo Park
Co-Investments: 3
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
AI
North America, Michigan, United States, Auburn Hills
Co-Investments: 3
AB
North America, New York, United States, New York
Co-Investments: 3
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
JAFCO
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Rho Ventures
North America, New York, United States, New York
Co-Investments: 3
New Venture Partners
North America, New Jersey, United States, Berkeley Heights
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 5

What are some of recent deals done by Yasuda Enterprise Development?

Ubiquisys

Swindon, Wiltshire, United Kingdom

Ubiquisys is a developer of multimode LTE, 3G and Wi-Fi small cells for mobile operators and consumers.

Communication HardwareMobileTelecommunications
Series UnknownAug 15, 2012
Amount Raised: $19,000,000
Topica Pharmaceuticals

Palo Alto, California, United States

TOPICA Pharmaceuticals is a clinical research stage company focused on developing topical treatment for fungal infections of the nail.

BiotechnologyMedical DevicePharmaceutical
Series BOct 18, 2011
Amount Raised: $27,000,000
Synageva BioPharma

Waltham, Massachusetts, United States

Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownMar 21, 2011
Amount Raised: $25,000,000
Ubiquisys

Swindon, Wiltshire, United Kingdom

Ubiquisys is a developer of multimode LTE, 3G and Wi-Fi small cells for mobile operators and consumers.

Communication HardwareMobileTelecommunications
Series UnknownJul 12, 2010
Amount Raised: $9,000,000
SymBio Pharmaceuticals

Tokyo, Tokyo, Japan

SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series UnknownDec 11, 2009
Amount Raised: $24,704,501
Synageva BioPharma

Waltham, Massachusetts, United States

Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series FOct 22, 2009
Amount Raised: $12,000,000
Kovio

San Jose, California, United States

Kovio is a semiconductor company that designs and manufactures printed silicon products.

Artificial Intelligence (AI)ConsultingElectronicsManufacturingSemiconductor
Series EJul 13, 2009
Amount Raised: $20,000,000
ZettaCore

Englewood, Colorado, United States

ZettaCore, pioneering the field of molecular electronics, is focused on developing molecular materials for the electronics industry.

ElectronicsEnergyNanotechnology
Series UnknownMay 11, 2009
Amount Raised: $21,000,000
Maneo

Tokyo, Tokyo, Japan

Maneo is a first Social Lending Marketplace in Japan.

FinanceMarketplaceSocial
Series UnknownDec 17, 2008
Amount Raised: $2,131,675
Osprey Pharmaceuticals USA

San Francisco, California, United States

Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.

BiotechnologyMedicalPharmaceutical
Series ASep 3, 2008
Amount Raised: $11,000,000